ALA PLUS TOH DOWN is a one-of-a-kind supplement that is composed of 5-ALA and iron to improve mitochondrial function and regulate blood glucose levels.
An oral intake of 5-ALA would be a novel approach to prevent type 2 diabetes mellitus. (Nutrition 29 (2013) 1030–1036)
5-ALA with SFC is a safe and potentially beneficial supplement if taken by diabetic patients treated with OHAs. (Functional Foods in Health and Disease 2014; 4(9):415-428)
Benefits Of ALA PLUS TOH DOWN
Enhance Sugar Metabolism
Regulate Blood Sugar
Increase Energy Level
Reduce Visceral Fat
High Antioxidant Effect
Recommended For Diabetics
WHO IS ALA PLUS TOH DOWN FOR?
Our daily health supplement is ideal for all users who desire preventive healthcare against lifestyle diseases such as Diabetes. It is not just for those who are diabetic or pre-diabetic. While you should always watch your diet, exercise regularly and follow your doctor’s advice closely, you should take a proactive management approach towards your health. For a happier life and for your family.
DIABETIC CONTROL & MANAGEMENT SUPPORT
Wondering how it works? By harnessing the powerful 5-ALA extracted through special patented fermentation process, this natural but special formula helps to improve glucose metabolism. With normalized glucose metabolism through supplementing 5-ALA and the right diet intake, the stagnation of glucose metabolism can be improved and the decrease of energy metabolism can be addressed. This helps to fight against the harmful effects of diabetes, which can lead to serious consequences if not controlled. The consequences could range from health risks related to your body’s organs and tissues – including your heart, kidneys, eyes and nerves.
IT IS SAFE TO TAKE WITH DIABETIC DRUGS
Published in 2019, Journal of Diabetes Research by concluded that 5-ALA phosphate with sodium ferrous citrate (SFC) is safe in patients taking oral antidiabetic medications such as:
1) Metformin (Biguanide)
2) Sulfonylurea (Glipizide, Gliclazide, and Glimepiride)
3) Meglitinides (Repaglinide and Nateglinide)
4) Thiazolidinediones (Rosiglitazone and Pioglitazone)
5) GLP Agonists (Exenatide, Lixisenatide, Liraglutide, Albiglutide and Dulaglutide)
6) DPP4 Inhibitors (Sitagliptin, Saxagliptin, Linagliptin and Alogliptin)
7) Sodium Glucose Co-Transporter-2 Inhibitors, SGLT2 (Gliflozins)
8) Alpha-Glucosidase Inhibitors (Acarbose, Miglitol and Voglibose)
9) Orlistat (Lipase Inhibitor)